Abstract
To demonstrate the large potential of proton minibeam radiotherapy (pMBRT) as a new method to treat tumor diseases, a preclinical proton minibeam radiation facility was designed. It is based on a tandem Van-de-Graaff accelerator providing a 16 MeV proton beam and a 3 GHz linac post-accelerator (designs: AVO-ADAM S.A, Geneva, Switzerland and ENEA, Frascati, Italy). To enhance the transmission of the tandem beam through the post-accelerator by a factor of 3, two drift tube buncher units were designed and constructed: A brazed 5-gap structure (adapted SCDTL tank of the TOP-IMPLART project (ENEA)) and a non-brazed low budget 4-gap structure. Both are made of copper. The performance of the two differently manufactured units was evaluated using a 16 MeV tandem accelerator beam and a Q3D magnetic spectrograph. Both buncher units achieve the required summed voltage amplitude of 42 kV and amplitude stability at a power feed of less than 800 W.
Publisher
Public Library of Science (PLoS)
Reference37 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;H Sung;CA: a cancer journal for clinicians,2021
2. European cancer mortality predictions for the year 2020 with a focus on prostate cancer;G Carioli;Annals of Oncology,2020
3. New frontiers in proton therapy: applications in cancers;TZ Yuan;Cancer Communications,2019
4. Reduced side effects by proton microchannel radiotherapy: study in a human skin model;O Zlobinskaya;Radiation and environmental biophysics,2013
5. Proton-minibeam radiation therapy: A proof of concept;Y Prezado;Medical physics,2013
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献